HROW
Harrow Inc Com
Company Overview
| Mkt Cap | $1.41B | Price | $37.77 |
| Volume | 497.27K | Change | +0.56% |
| P/E Ratio | -80.8 | Open | $37.68 |
| Revenue | $199.6M | Prev Close | $37.56 |
| Net Income | $-17.5M | 52W Range | $20.85 - $54.19 |
| Div Yield | N/A | Target | $67.91 |
| Overall | 26 | Value | 20 |
| Quality | -- | Technical | 33 |
No chart data available
Stock Overview
Updated DailyHarrow Inc Com (HROW) is a leading Healthcare company in the Drug Manufacturers - Specialty & Generic industry, currently trading at $37.77 with a market capitalization of $1.41 billion. The stock is trading in the middle of its 52-week range, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows HROW with a volume of 497K shares. The stock opened up 0.32% from yesterday's close of $37.56. Current analyst estimates project earnings of $0.43 per share for this year, with next year targeting $1.8.
HROW demonstrates concerning technical signals based on technical analysis. The company trades on the NSD exchange and operates alongside industry peers including OMHE, OILS-CA, OGN, ONPH.
Key investment considerations for HROW include concerning overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 79.8%. The stock shows expensive valuation metrics based on valuation analysis.
Analysis generated on November 2, 2025 at 03:39 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | HROW | $37.77 | +0.6% | 497.27K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |